MX100, a new Escerichia coli tester strain for use in genotoxicity studies. by Kranendonk, M. et al.
VU Research Portal
MX100, a new Escerichia coli tester strain for use in genotoxicity studies.




DOI (link to publisher)
10.1093/mutage/11.4.327
document version
Publisher's PDF, also known as Version of record
Link to publication in VU Research Portal
citation for published version (APA)
Kranendonk, M., Pintado, F., Mesquita, P., Laires, A., Vermeulen, N. P. E., & Rueff, J. (1996). MX100, a new
Escerichia coli tester strain for use in genotoxicity studies. Mutagenesis, 11(4), 327-333.
https://doi.org/10.1093/mutage/11.4.327
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Download date: 23. May. 2021
MutagenesU vol.11 no.4 pp.327-333, 1996
MX100, a new Escherichia coli tester strain for use in genotoxicity
studies
M.Kranendonk1-2, F.Pintado1, P.Mesquita1, A.Laires1-3,
N.P.E.Vermeulen2 and J.Rueff1-4
'Department of Genetics, Faculty of Medical Sciences, New University of
Lisbon, R. de Junqueira 96, P-1300, Lisbon, Portugal, 2Leiden/Amsterdam
Centre for Drug Research (LACDR), Division of Molecular Toxicology,
Free University of Amsterdam, De Boelelaan 1083, 1081 HV Amsterdam,
The Netherlands and 3Faculty of Sciences and Technology, New University
of Lisbon, P-2825 Monte de Caparica, Portugal
•*To whom correspondence should be addressed
The development of a new Escherichia coli tester strain
for use in metabolic and mechanistic studies of genotoxins,
strain MR2101/pKRll, has recently been reported. This
strain, a derivative of the E.coli K12 laboratory strain
AB1157, has sensitivity towards the detection of base-
substitution mutagenesis, monitored by the reversion of
arginine auxotrophy [argE3, (ochre)]. Besides arginine,
MR2101/pKRll is auxotrophic for histidine (hisG4), leucine
(leuB6), proline (AproA) and threonine (thr-1). MX100 was
developed to overcome the auxotrophy for four amino
acids of MR2101/pKRll which are non-essential for the
mutagenic responsiveness of the strain. We restored the
biosynthesis for these four amino acids in MR2101/pKRll,
resulting in strain MX100. This strain showed an almost
2-fold increase in mutagenic activity relative to MR2101/
pKRll with a set of diagnostic mutagens (aflatoxin Bl,
benzo[a]pyrene, 4-nitroquinoline-l-oxide, 2,7-dimethyl-
benz[a]anthracene and others) and was further character-
ized with other types of mutagens in which it showed
sensitivity towards the detection of oxidative (H2O2, f-butyl-
hydroperoxide, cumene-hydroperoxide, KO2) and car bony 1
mutagens (methylglyoxal, malondialdehyde). As MX 100
seems to have the right characteristics of a versatile
genotoxicity tester strain and due to the extensive genetic
and physiological knowledge of E.coli K12 in general and
AB1157 in particular, we propose that MX 100 could serve
as mother strain for the development of specialized tester
strains, of interest in studies of metabolism and/or mechan-
ism of action of genotoxic carcinogens.
Introduction
We developed recently a new Escherichia coli K12 tester
strain, MR2101/pKRl 1, for the study of genotoxic mechanisms
and metabolism studies of chemicals (Kranendonk et ai,
1994a,b) in which our laboratory has been involved for a
number of years (Rueff et ai, 1992a,b; Kranendonk et ai,
1993, Rodrigues et ai, 1993, 1994; Gaspar et ai, 1994). The
strain is defective in the lipopolysaccharide core (LPSd), part
of the outer membrane, but contains a partial deletion of uvrA,
a component of DNA excision repair and a newly constructed
mutator plasmid (pKRll), a derivative of pKMlOl, carrying
the SOS-inducible mucAB system. The genetic target by which
the chemical mutagenesis is assessed consists of a point
mutation (ochre) in the arginine biosynthetic operon (argE3)
© UK Environmental Mutagen Society/Oxford University Press 1996
which renders the bacterium unable to grow in the absence of
arginine. The mutagenicity test is based on monitoring the
back mutation to arginine independence which can occur via
all possible transition and transversion base-substitutions (Todd
et al, 1979).
We report here on the development and characterization of
an improved derivative of MR2101/pKRll, strain MX100. This
new strain showed increased mutagenic responses relatively to
MR2101/pKRll for a number of mutagens. The results pre-
sented here seem to characterize MX 100 as a versatile geno-
toxicity tester strain which can be applied in a plate assay as
well as in a liquid-preincubation assay, and which shows
sensitivity towards a variety of different classes of genotoxins,
including oxidative and carbonyl mutagens. Based on these
characteristics and the extensive genetic and physiological
knowledge of E.coli K12 in general and AB1157 in particular,
we propose that MX 100 could serve as the mother strain for
the development of specialized tester strains, of particular




L-Histidine (L-his), r>glucose monohydrate, crystal violet, sodium azide
(NaN3), 2-nitrofluorene (2NF), malondialdehyde (MDA), H2O2 and dimethyl
sulphoxide (DMSO) were obtained from Merck (Darmstadt, Germany). The
amino acids L-proline (L-pro), L-leucine (L-leu), L-threonine (L-thr) and L-
arginine (L-arg) as well as sodium deoxycholate, ethidium bromide, 7,12-
dimethylbenz[a]anthracene (DMBA), pyrene, cumene-hydroperoxide (CHP),
/-butyl-hydroperoxide (tBHP), methylglyoxal (MG), quercetin (Q), mitomycin
C (MMC), potassium superoxide (KO2) and 4-nitroquinoline-l-oxide (4NQO)
were purchased from Sigma (St Louis, MO, USA). Ampicilhn (sodium salt)
and tetracycline-HCI were from Northumbria Biologicals (Northumberland,
UK). Bacto agar, bacto trypton, bacto yeast extract and bacto MacConkey
agar were from Difco (Detroit, MI, USA); nutrient broth (NB) (Fluka, Buchs,
Switzerland), thiamine (diphosphate form: triphosphoneurina) (Biofranco,
Lisbon, Portugal) and aflatoxin Bl (AFB1) were from Aldnch (Madrid,
Spain). The antibiotic kanamycin sulfate was obtained from Boehringer-
Mannheim (Mannheim, Germany). Benzo[a]pyrene (B[a]P) was a gift from
Pasteur Institute (Paris). Mutagens were dissolved in DMSO, except for CHP,
MG, H2O2, KO2 and NaN3, which were dissolved in water.
Strains and microbiological media
All microbiological media were as described previously (Kranendonk et ai,
1994a). P|vlr transductions and isolation of lipopolysaccharide-defective (LPSd)
mutants were performed as described previously (Kranendonk el ai, 1994a).
The genotype and the origin of the different strains are shown in Table I.
Mutagenicity assays
Plate-incorporation assay. The mutagenicity plate-incorporation assays with
MR210l/pKRI I and TA100 were performed as previously described (Kranen-
donk et ai, 1994a; Maron and Ames, 1983 respectively). MXI0O was applied
accordingly, without the addition of the four amino acids L-his, L-leu, L-pro
and L-thr to the tester plates, unless otherwise stated
Liquid-preincubation assay. The mutagenicity assays with the mutagens H2O2,
CHP, KO2, tBHP, MG and MDA were performed in a liquid-prcincubation
assay with strains TAI02 and TA104, as described by Maron and Ames
(1983) with minor modifications (Abu-Shakra and Zeiger, 1990). MX100 was
employed in the same way using 1-2X10* stationary phase cells.
At least three independent determinations were carried out for each dose
level. Mutagenic activities were determined from the slope as the least-squares





































thr-1, ara-14, leuB6, A(gpt-pmA)62, lacYl, tsx-33, qsr, supE44, galK2, X',
























this paper (PI[MM294]XMR2IOO to His+)
this paper (PI[MM294]XFPI00 to Pro+)
this paper (PI[MM294]XFP200 to Leu+)
this paper (PI[MM294]XFP300 to Thr+)










Development of strain MX100
The E.coli K12 strain MR2101/pKRll, a derivative of the
laboratory strain AB1157 (see Table I), seems to have the
necessary characteristics of a genotoxicity tester strain,
developed especially for mechanistic and metabolic studies of
mutagens (Kranendonk et al., 1994a,b). Besides the arginine
auxotrophy, due to the argE3 mutation which constitutes the
genetic target, it is auxotrophic for histidine [hisGA (ochre)],
leucine (leuBS), proline (AproA) and threonine [thr-l (amber)],
which is the origin of the impractical addition (in excess) of
these four amino acids to the tester plates. We decided to
restore the biosynthesis capacity of these four amino acids by
four subsequent P,™ transactions using an appropriate donor
strain to remedy the four afflicted genes in MR2101/pKRll.
The arginine reversion by which mutagenicity is assessed can
occur via (i) structural reversion of the argE3 (ochre) mutation
to a sense codon or conversion to an amber codon which can
be suppressed by the supE44 mutation; (ii) ochre suppressor
formation de novo; or (iii) suppressor conversion of supE44
to supB (Todd et al, 1979). These mutations cover all possible
transitions and transversion base-substitutions. The donor strain
[MM249 (supE44); see Table I] was chosen carefully so that
no interfering mutations would be introduced. In this way all
the elements of the genetic target were maintained and the
prototrophy for the four amino acids was in principle restored
by the introduction of the wild-type form of the four afflicted
genes but not by the introduction of a new suppressor mutation.
The only way proline prototrophy could be restored was by
introduction of the wild-type gene of proA as this gene is deleted
in MR2101/pKRll. The four P1[MM294] transductions were
carried out with the LPS+ predecessor of strain MR2101
(MR2100; see Table I) as LPS5 bacteria are (partially) resistant
to P, infection (Austin et al, 1990; Parker et al, 1992). A
stable LPSd mutant was isolated (FP401) with high permeability
towards bulky compounds, which was similar to the one found
for MR2101 (data not shown). Subsequently our mutator
plasmid pKRl 1 (Kranendonk et al, 1994a) carrying the mucAB
operon was introduced, resulting in strain MX 100.
Mutagenicity testing with MX100
Before employing MX 100 in mutagenicity assays, monitoring
the arginine reversion, the optimum trace amount of arginine
was verified, as determined before for MR2101/pKRU, to
allow a limiting number of DNA replications of the tester
bacteria in the presence of the test compound. This growth
leads to a more accessible DNA target and allows the processing
of the DNA lesion into a mutation (genetic fixation) (Mohn
et al, 1984). The optimal L-arg concentration (1 (ig/ml)
was found to be equal to that found for MR2101/pKRU
(Kranendonk et al, 1994a). In these optimal conditions 205
revertants were picked up arbitrarily from different tester plates
induced by different test compounds (see below) and checked
for their true Arg+ character. All 205 revertants maintained
their Arg+ character on subculture. A set of diagnostic com-
pounds [as used by Kranendonk et al. (1994a)] was tested
with MX 100 and compared with MR2101/pKRll (see Table
II). Almost all mutagens showed an increase in mutagenic
activity (in revertants/nmol) with MX100 relative to MR2101/
pKRll, except for sodium azide [false positive of TA100
(McCann et al, 1975)] and pyrene, which both remained
negative. On average, the mutagenic response of MX 100 was
increased almost 2-fold relative to MR2101/pKRll (1.70 ±
0.01, r = 0.999) for the compounds tested (see Figure 1). As
the LPSd mutations of MX100 and MR2101/pKRll were
isolated independently, the increase in responsiveness could
be due to differences in the ease of penetration of the test
compounds. This hypothesis is excluded as both strains showed
similar permeabilities of the LPS core. The composition of
the tester plate of the two E.coli strains differ as the four
amino acids could be omitted from the MX 100 tester plates.
To verify whether the four amino acids could influence the
magnitude of the mutagenic response, the mutagenic activity
of 4NQO was determined in MR2101/pKRll and MX100
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Fig. 1. Correlation of specific mutagenic activities of strain MR2101/pKRll
against MX100. Mutagenic activities were determined as the least-squares
line of the linear portion of the dose-response curve.
plates, as for MR2101/pKRll (see Figure 2). The mutagenic
response of MX 100 for 4NQO in the presence of the amino
acids regressed to the level of that found for MR2101/pKRll.
We have found this effect for other mutagens (data not shown).
The presence of the amino acids seem to diminish the mutagenic
responsiveness of MX100 and it seems that, because they
could be omitted from the minimal tester medium, the muta-
genic response of MX100 is improved.
Further characterization of MX 100
We extended the number of test compounds to further character-
ize MX 100 and to verify the sensitivity of the arginine target
towards other classes of mutagens. Our laboratory is involved
in studies of oxidative mutagenesis (Almeida et al, 1992;
Crist6vao et al, 1992; Rueff et al, 1992a, 1993; Gaspar et al,
1994). MX100 was therefore tested with H2O2, CHP, tBHP
and KO2, to determine the usefulness of MX 100 for such
studies, and was compared with strain TA102, which together
with strain TA104 was originally developed for the detection
of oxidative mutagens (Levin et al, 1982) (see Table ID). The
mutagenic responses of these compounds were determined in
a liquid-preincubation assay in which oxidative mutagens seem
to be more readily detected (Abu-Shakra and Zeiger, 1990).
The results show that MX 100 is sensitive towards the detection
of this class of mutagen, and can be employed effectively in
a liquid-preincubation assay. Moreover, MX 100 has a stable
low background reversion (in spontaneous revertants) in con-
trast to the two Salmonella strains, which forms a major
practical drawback, especially for TA102 (Jung et al, 1992).
The genetic target in TA102 and TA104 is constituted by the
hisG42S (ochre) mutation, which is located plasmid-bome in
TA102 and genomically in TA104. Furthermore, TA104 is
hampered in DNA excision repair (uvrB), in contrast to TA102
(uvr+). The His reversion of these strains seems to occur
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Fig. 2. Mutagenic activity of 4NQO in strains MR2l01/pKRl 1 and MX 100
with and without the amino acids L-his, L-leu, L-pro and L-thr as applied for
MR2101/pKRll (100 Jig/ml, final plate concentration). MXIOO": without
the amino acids; MXIOO"1": with the amino acids.
mutations outside the his operon (Levin et al, 1982). The
target is therefore constituted only by A:T base pairs which
are equally present in the argE3 (ochre) mutation of MX100,
forming indicators for the observed sensitivity of MX100 for
oxidative mutagens. This is in concordance with the sensitivity
of the Trp+ reversion in the E.coli tester strain WP2 containing
the trpE (ochre) mutation towards the detection of oxidative
mutagens (Wilcox et al, 1990). MX100 is more closely related
to TA104 than to TA102, as both are excision repair deficient
and contain both genomic (ochre) targets (see Table I). TA104
has been shown to be sensitive towards the detection of
carbonyl mutagens which apparently have an oxidative com-
ponent in their mutagenic action (Mamett et al, 1985; Ueno
et al, 1991). MX100 was therefore subsequently tested with
two carbonyl mutagens [methylglyoxal (MG) and malondial-
dehyde (MDA)], in comparison with TA104 (see Table HI).
TA102 and TA104 differ in their sensitivity towards the
detection of DNA cross-linking agents which require an active
excision repair for mutagenic activity (Levin et al, 1982).
This is confirmed by the results obtained with the DNA cross-
linker mitomycin C (MMC) in the strains TA102, TA104 and
MX100 (see Table IE). The results obtained with the last three
compounds seem to confirm the structural similarities between
MX100 and TA104 and therefore the abilities of MX100 to
detect oxidative mutagens.
Discussion
We have described here the development and characterization
of MX100, an improved derivative of MR2101/pKRll. MX100
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Results are shown as means representing at least three independent determinations for each dose-level ± SD.
was developed to overcome the auxotrophy of MR2101/pKRl 1
for four amino acids which are non-essential for the mutagenic
responsiveness of the strain. The biosynthesis of these amino
acids was restored in such a way that in principle no undesired
genetic alterations were introduced which could interfere with
the different ways of the arginine back mutation, as the hisGA,
leuB6 and thr-l mutations can be suppressed by specific













Table FV. Comparison of mutagenic activity of various mutagens in strain MXlOO versus the routinely used strains E.coli WP2 and Salmonella TA100 and
TA102






















1, 2, 3, 5
'Mutagenicity: (+), mutagenic; (—), non-mutagenic.
•"References: 1, Brusick et al. (1980); 2, Kranendonk et al. (1994); 3, this paper, 4, Dyrby and Ingvardsen (1983); 5, Wilcox et al. (1990).
have nullified part of the (multiple) arginine target which
would have led to a decrease in mutagenic responsiveness. As
the opposite was found, it is concluded that the restored
biosynthesis pathways in MXlOO are due to the substitution
of the afflicted genes.
MXlOO showed an almost 2-fold increase in specific
mutagenic activity with a set of diagnostic compounds relative
to MR2101/pKRll. The compositions of the tester plate of
the two E.coli strains differ as the four amino acids could be
omitted from the MXlOO tester plates. We showed that it is
probably because of this omission that MXlOO seems to be
improved. It is tempting to speculate that amino acid starvation
of MXlOO relative to MR2101/pKRll could, in a way similar
to glucose starvation (Kopsidas and MacPhee, 1993), diminish
the efficiency of error-free repair with a parallel augmented
error-prone repair, explaining the observed increase in muta-
genic activity for MXlOO.
We showed here that the back mutation can also be induced
by known oxidative and carbonyl mutagens. The results
obtained for MXlOO with the wide spectrum of different
mutagens reflects the different ways by which the arginine
auxotrophy can revert, covering all possible transitions and
transversions. This indicates the versatility of the arginine back
mutation as the genetic target in MXlOO and seems to
characterize MXlOO as a tester strain which can be of interest
in studies of the mode of action of mutagens with multiple
genotoxic effects. Table IV shows a comparison of muta-
genicity results obtained in MXlOO versus routinely used
tester strains, namely E.coli WP2 and Salmonella strains,
demonstrating that the responses of MXlOO match the ones
found in the other tester strains. MXlOO could, however, have
some advantages over the routinely used tester strains in
mechanistic and metabolic studies of genotoxins because
MXlOO is derived from the E.coli K12 laboratory strain
AB1157, a strain which is genetically very well characterized
for DNA repair, especially for SOS mutagenesis (Langer et al.,
1981, 1985; Sedgwick and Goodwin, 1985; Donnelly and
Walker 1989, 1992; Sedgwick et al., 1991; Sommer et al.,
1993). Moreover, AB1157 has been shown to be one of the
more mutable E.coli strains (Sedgwick et al., 1991).
The loci of genes whose products could be involved in
metabolism of genotoxins are in general best characterized in
E.coli K12 relative to other prokaryotes (Mohn et al, 1984;
Kranendonk et al, 1994a). This can be beneficial in studies
of the involvement of bacterial metabolism in the mutagenic
effect of genotoxins. Escherichia coli is an attractive organism
for studies of the involvement of the different repair mechan-
332
isms in mutagenesis, as these mechanisms occur in E.coli via
basic molecular processes which have their counterparts in
higher, though much more complex, cells (Walker, 1985;
Sancar and Sancar, 1988), such as recombinational repair
(Kowalczykowski et al, 1994), excision repair (Barnes et al,
1993) and mismatch repair (Lindahl, 1994). This last mentioned
repair has been in focus recently, demonstrating the importance
of mutagenesis studies in E.coli and the application of strain
AB1157, due to the characterization of a locus in the human
genome, coding for human MSH2, a homologue of E.coli Mut
S and yeast MSH, the mutation of which is associated with
hereditary non-polyposis colon cancer (HNPCC) (Fishel et al,
1993). The expression of human MSH2 in E.coli (AB1157)
demonstrated a physiological activity in E.coli mismatch repair
(Fishel et al, 1993).
It is due to the above described characteristics of E.coli in
general and AB1157 and MXlOO in particular that we propose
here that MXlOO could serve as the mother strain for the
development of specialized tester strains, of interest in studies
of metabolism and/or the mechanism of action of genotoxic
carcinogens. These can be: (i) introduction of specific genetic
targets (either genomic or plasmid-borne) by which the prefer-
ences of mutations induced by specific genotoxins can be
studied; (ii) inactivation or overexpression of genes whose
products are involved in specific DNA repair mechanisms, by
which the involvement of specific DNA repair processes in
the induction of specific mutations can be determined; (iii)
inactivation or overexpression of specific bacterial genes whose
products could be involved in the bio(in)activation of pre-
genotoxins; and (iv) expression of specific mammalian meta-
bolizing enzymes. The latter is especially of interest because
in the last few years much effort has been put into the
unravelling of human metabolic pathways, involved in bio(in)-
activation of genotoxins. One of the more promising approaches
is the direct introduction of genes/cDNAs of mammalian
metabolizing enzymes in the genotoxicity assay target cell
(Gonzalez et al, 1991; Rodrigues et al, 1993). Escherichia
coli seems to be particularly appropriate for this application
(Kranendonk et al, 1994b). At the moment, MXlOO is being
applied in all four mentioned areas.
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